1. Cunningham-Rundles, C., How I treat common variable immune deficiency. Blood, 2010. 116(1): p. 7-15.
2. Thaventhiran, J.E.D., et al., Whole-genome sequencing of a sporadic primary immunodeficiency cohort. Nature, 2020. 583(7814): p. 90-95.
3. Jørgensen, S.F., B. Fevang, and P. Aukrust, Autoimmunity and Inflammation in CVID: a Possible Crosstalk between Immune Activation, Gut Microbiota, and Epigenetic Modifications. J Clin Immunol, 2019. 39(1): p. 30-36.
4. Resnick, E.S., et al., Morbidity and mortality in common variable immune deficiency over 4 decades. Blood, 2012. 119(7): p. 1650-7.
5. Jørgensen, S.F., et al., Altered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activation. Mucosal Immunol, 2016. 9(6): p. 1455-1465.
6. Macpherson, M.E., et al., Impaired HDL Function Amplifies Systemic Inflammation in Common Variable Immunodeficiency. Sci Rep, 2019. 9(1): p. 9427.
7. Calder, P.C., Functional Roles of Fatty Acids and Their Effects on Human Health. JPEN J Parenter Enteral Nutr, 2015. 39(1 Suppl): p. 18s-32s.
8. Gutiérrez, S., S.L. Svahn, and M.E. Johansson, Effects of Omega-3 Fatty Acids on Immune Cells. Int J Mol Sci, 2019. 20(20).
9. Calder, P.C., Long-chain fatty acids and inflammation. Proc Nutr Soc, 2012. 71(2): p. 284-9.
10. Del Gobbo, L.C., et al., ω-3 Polyunsaturated Fatty Acid Biomarkers and Coronary Heart Disease: Pooling Project of 19 Cohort Studies. JAMA Intern Med, 2016. 176(8): p. 1155-66.
11. Wu, J.H.Y., et al., Omega-6 fatty acid biomarkers and incident type 2 diabetes: pooled analysis of individual-level data for 39 740 adults from 20 prospective cohort studies. Lancet Diabetes Endocrinol, 2017. 5(12): p. 965-974.
12. Sonnenburg, J.L. and F. Bäckhed, Diet-microbiota interactions as moderators of human metabolism. Nature, 2016. 535(7610): p. 56-64.
13. Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. International Union of Immunological Societies. Clin Exp Immunol, 1999. 118 Suppl 1(Suppl 1): p. 1-28.
14. Chapel, H., et al., Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood, 2008. 112(2): p. 277-86.
15. Jørgensen, S.F., et al., Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency. Sci Rep, 2019. 9(1): p. 167.
16. Strand, E., et al., Long-term treatment with the pan-PPAR agonist tetradecylthioacetic acid or fish oil is associated with increased cardiac content of n-3 fatty acids in rat. Lipids Health Dis, 2012. 11: p. 82.
17. Calder, P.C., Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? Br J Clin Pharmacol, 2013. 75(3): p. 645-62.
18. Ramsvik, M.S., et al., A Phospholipid-Protein Complex from Krill with Antioxidative and Immunomodulating Properties Reduced Plasma Triacylglycerol and Hepatic Lipogenesis in Rats. Mar Drugs, 2015. 13(7): p. 4375-97.
19. Ahlquist, D.A., et al., A stool collection device: the first step in occult blood testing. Ann Intern Med, 1988. 108(4): p. 609-12.
20. Wu, G.D., et al., Sampling and pyrosequencing methods for characterizing bacterial communities in the human gut using 16S sequence tags. BMC Microbiol, 2010. 10: p. 206.
21. Kozich, J.J., et al., Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. Appl Environ Microbiol, 2013. 79(17): p. 5112-20.
22. Andersen, L.F., et al., Evaluation of a food frequency questionnaire with weighed records, fatty acids, and alpha-tocopherol in adipose tissue and serum. Am J Epidemiol, 1999. 150(1): p. 75-87.
23. Andersen, L.F., et al., Evaluation of three dietary assessment methods and serum biomarkers as measures of fruit and vegetable intake, using the method of triads. Br J Nutr, 2005. 93(4): p. 519-27.
24. Wanders, A.J., et al., Circulating Polyunsaturated Fatty Acids as Biomarkers for Dietary Intake across Subgroups: The CODAM and Hoorn Studies. Ann Nutr Metab, 2018. 72(2): p. 117-125.
25. Astorg, P., et al., Plasma n-6 and n-3 polyunsaturated fatty acids as biomarkers of their dietary intakes: a cross-sectional study within a cohort of middle-aged French men and women. Eur J Clin Nutr, 2008. 62(10): p. 1155-61.
26. Totland TH, M.B., Lunberg-Hallen N, Helland-Kigen KM, Lund-Blix NA, Myhre JB, Johansen AMW, Løken EB, Andersen LF, Norkost 3 En landsomfattende kostholdsundersøkelse blant menn og kvinner i Norge i alderen 18-70 år, 2010-11. 2012(IS-2000).
27. Jørgensen, S.F., et al., Selective IgA deficiency in humans is associated with reduced gut microbial diversity. J Allergy Clin Immunol, 2019. 143(5): p. 1969-1971.e11.
28. D'Angelo, S., M.L. Motti, and R. Meccariello, ω-3 and ω-6 Polyunsaturated Fatty Acids, Obesity and Cancer. Nutrients, 2020. 12(9).
29. Sokoła-Wysoczańska, E., et al., Polyunsaturated Fatty Acids and Their Potential Therapeutic Role in Cardiovascular System Disorders-A Review. Nutrients, 2018. 10(10).
30. Marventano, S., et al., A review of recent evidence in human studies of n-3 and n-6 PUFA intake on cardiovascular disease, cancer, and depressive disorders: does the ratio really matter? Int J Food Sci Nutr, 2015. 66(6): p. 611-22.
31. Burdge, G.C. and P.C. Calder, Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reprod Nutr Dev, 2005. 45(5): p. 581-97.
32. Baylin, A. and H. Campos, The use of fatty acid biomarkers to reflect dietary intake. Curr Opin Lipidol, 2006. 17(1): p. 22-7.
33. de Oliveira Otto, M.C., et al., Circulating and dietary omega-3 and omega-6 polyunsaturated fatty acids and incidence of CVD in the Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc, 2013. 2(6): p. e000506.
34. Schoeler, M. and R. Caesar, Dietary lipids, gut microbiota and lipid metabolism. Rev Endocr Metab Disord, 2019. 20(4): p. 461-472.
35. Wolters, M., et al., Dietary fat, the gut microbiota, and metabolic health - A systematic review conducted within the MyNewGut project. Clin Nutr, 2019. 38(6): p. 2504-2520.
36. Costantini, L. and N. Merendino, Polyunsaturated Fatty Acids and Microbiota Relationship: Implications in Cancer Onset and Treatment. J Clin Med, 2020. 9(11).
37. Costantini, L., et al., Impact of Omega-3 Fatty Acids on the Gut Microbiota. Int J Mol Sci, 2017. 18(12).
38. Org, E., et al., Relationships between gut microbiota, plasma metabolites, and metabolic syndrome traits in the METSIM cohort. Genome Biol, 2017. 18(1): p. 70.
39. Horigome, A., et al., Association between blood omega-3 polyunsaturated fatty acids and the gut microbiota among breast cancer survivors. Benef Microbes, 2019. 10(7): p. 751-758.
40. Fritsche, K.L., Too much linoleic acid promotes inflammation-doesn't it? Prostaglandins Leukot Essent Fatty Acids, 2008. 79(3-5): p. 173-5.